{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:52:51Z","timestamp":1791665571009,"version":"4.3.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006679","name":"Kobayashi Magobe Memorial Medical Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006679","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Okayama Medical Foundation"},{"name":"Research Group for Schizophrenia"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.euroneuro.2018.03.004","type":"journal-article","created":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T01:36:34Z","timestamp":1521596194000},"page":"610-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Effects of the antipsychotics haloperidol, clozapine, and aripiprazole on the dendritic spine"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5498-551X","authenticated-orcid":false,"given":"Manabu","family":"Takaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Mizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bunta","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Okahisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihito","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.euroneuro.2018.03.004_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.schres.2010.08.011","article-title":"Effects of aripiprazole and haloperidol on progression to schizophrenia-like behavioral abnormalities and apoptosis in rodents","volume":"125","author":"Abekawa","year":"2011","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.euroneuro.2018.03.004_bib2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/mp.2010.110","article-title":"Disrupted in Schizophrenia-1 regulates intracellular trafficking of mitochondria in neurons","volume":"16","author":"Atkin","year":"2011","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2018.03.004_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jnr.10440","article-title":"Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs","volume":"71","author":"Bai","year":"2003","journal-title":"J. Neurosci. Res."},{"issue":"14","key":"10.1016\/j.euroneuro.2018.03.004_bib4","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.0307921101","article-title":"Lithium antagonizes dopamine-dependent behaviors mediated by an AKT\/glycogen synthase kinase 3 signaling cascade","volume":"101","author":"Beaulieu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.euroneuro.2018.03.004_bib5","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1176\/appi.ajp.2012.12070908","article-title":"Association of GSK-3\u03b2 genetic variation with GSK-3\u03b2 expression, prefrontal cortical thickness, prefrontal physiology, and schizophrenia","volume":"170","author":"Blasi","year":"2013","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2018.03.004_bib6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1083\/jcb.86.3.831","article-title":"Isolation and characterization of postsynaptic densities from various brain regions: enrichment of different types of postsynaptic densities","volume":"86","author":"Carlin","year":"1980","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.euroneuro.2018.03.004_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/sj.mp.4002106","article-title":"The DISC locus in psychiatric illness","volume":"13","author":"Chubb","year":"2008","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2018.03.004_bib8","first-page":"82","article-title":"Radioreceptor assays for neuroleptic drugs and clinical research in psychiatry","volume":"16","author":"Cohen","year":"1980","journal-title":"Psychopharmacol. Bull."},{"issue":"3","key":"10.1016\/j.euroneuro.2018.03.004_bib9","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1176\/appi.ajp.161.3.414","article-title":"Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies","volume":"161","author":"Correll","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.03.004_bib10","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.mcn.2006.05.007","article-title":"Clozapine and haloperidol differentially regulate dendritic spine formation and synaptogenesis in rat hippocampal neurons","volume":"32","author":"Critchlow","year":"2006","journal-title":"Mol. Cell. Neurosci."},{"issue":"Suppl 3","key":"10.1016\/j.euroneuro.2018.03.004_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00004850-199112003-00002","article-title":"Depression and 5HT","volume":"6","author":"Deakin","year":"1991","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.euroneuro.2018.03.004_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng1296","article-title":"Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia","volume":"36","author":"Emamian","year":"2004","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.euroneuro.2018.03.004_bib13","first-page":"245","article-title":"Studies on serum protein binding of haloperidol","volume":"21","author":"Forsman","year":"1977","journal-title":"Curr. Ther. Res. Clin. Exp."},{"issue":"4","key":"10.1016\/j.euroneuro.2018.03.004_bib14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/jnnp.65.4.446","article-title":"Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia","volume":"65","author":"Garey","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2018.03.004_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3940(03)00852-8","article-title":"Prenatal cocaine exposure alters glycogen synthase kinase-3beta (GSK3beta) pathway in select rabbit brain areas","volume":"349","author":"Gil","year":"2003","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.euroneuro.2018.03.004_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archpsyc.57.1.65","article-title":"Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia","volume":"57","author":"Glantz","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.03.004_bib17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neuroscience.2012.04.044","article-title":"Dendritic spine pathology in schizophrenia","volume":"251","author":"Glausier","year":"2013","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.euroneuro.2018.03.004_bib18","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/sj.npp.1300422","article-title":"Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus","volume":"29","author":"Halim","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.euroneuro.2018.03.004_bib19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nn.2487","article-title":"Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1","volume":"13","author":"Hayashi-Takagi","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.euroneuro.2018.03.004_bib20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archgenpsychiatry.2010.199","article-title":"Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia","volume":"68","author":"Ho","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"9","key":"10.1016\/j.euroneuro.2018.03.004_bib21","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.biopsych.2004.07.023","article-title":"Association of AKT1 with schizophrenia confirmed in a Japanese population","volume":"56","author":"Ikeda","year":"2004","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.euroneuro.2018.03.004_bib22","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2174\/1389450110607011421","article-title":"Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions","volume":"7","author":"Jope","year":"2006","journal-title":"Curr. Drug. Targets"},{"issue":"12","key":"10.1016\/j.euroneuro.2018.03.004_bib23","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/ncb1328","article-title":"A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development","volume":"7","author":"Kamiya","year":"2005","journal-title":"Nat. Cell Biol."},{"issue":"1-3","key":"10.1016\/j.euroneuro.2018.03.004_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.schres.2011.12.015","article-title":"Genetic overlap between schizophrenia and bipolar disorder: a study with AKT1gene variants and clinical phenotypes","volume":"135","author":"Karege","year":"2012","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.euroneuro.2018.03.004_bib25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/15622970701361255","article-title":"Serum levels of aripiprazole and dehydroaripiprazole, clinical response and side effects","volume":"9","author":"Kirschbaum","year":"2008","journal-title":"World J. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2018.03.004_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2004.02.003","article-title":"Low GSK-3beta in schizophrenia as a consequence of neurodevelopmental insult","volume":"15","author":"Kozlovsky","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2018.03.004_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ajmg.b.30498","article-title":"Increase in GSK3beta gene copy number variation in bipolar disorder","volume":"144B","author":"Lachman","year":"2007","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.euroneuro.2018.03.004_bib28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1196\/annals.1300.063","article-title":"Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment","volume":"1003","author":"Laruelle","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"9896","key":"10.1016\/j.euroneuro.2018.03.004_bib29","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"issue":"1\u20133","key":"10.1016\/j.euroneuro.2018.03.004_bib30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.schres.2011.09.013","article-title":"Genetic association and identification of a functional SNP at GSK3\u03b2 for schizophrenia susceptibility","volume":"133","author":"Li","year":"2011","journal-title":"Schizophr. Res."},{"issue":"8","key":"10.1016\/j.euroneuro.2018.03.004_bib31","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/sj.npp.1300439","article-title":"In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain","volume":"29","author":"Li","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.euroneuro.2018.03.004_bib32","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/bmc.2698","article-title":"Determination of aripiprazole in rat plasma and brain using ultra-performance liquidchromatography\/electrospray ionization tandem mass spectrometry","volume":"26","author":"Liang","year":"2012","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.euroneuro.2018.03.004_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archpsyc.62.4.361","article-title":"Antipsychotic drug effects on brain morphology in first-episode psychosis","volume":"62","author":"Lieberman","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"20","key":"10.1016\/j.euroneuro.2018.03.004_bib34","doi-asserted-by":"crossref","first-page":"11712","DOI":"10.1073\/pnas.1634990100","article-title":"Akt as a mediator of cell death","volume":"100","author":"Luo","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.euroneuro.2018.03.004_bib35","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.cell.2008.12.044","article-title":"Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta\/beta-catenin signaling","volume":"136","author":"Mao","year":"2009","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.euroneuro.2018.03.004_bib36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/JCP.0b013e31816774f9","article-title":"The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study","volume":"28","author":"Marcus","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2\u20133","key":"10.1016\/j.euroneuro.2018.03.004_bib37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0920-9964(03)00050-1","article-title":"Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials","volume":"61","author":"Marder","year":"2003","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.euroneuro.2018.03.004_bib38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00003088-200746050-00001","article-title":"Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response","volume":"46","author":"Mauri","year":"2007","journal-title":"Clin. Pharmacokinet."},{"issue":"6","key":"10.1016\/j.euroneuro.2018.03.004_bib39","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrn2392","article-title":"Neuregulin 1 in neural development, synaptic plasticity and schizophrenia","volume":"9","author":"Mei","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.euroneuro.2018.03.004_bib40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/1568007024606258","article-title":"N-methyl-D-aspartate receptor-coupled glycineB receptors in the pathogenesis and treatment of schizophrenia: a critical review","volume":"1","author":"Millan","year":"2002","journal-title":"Curr. Drug. Targets CNS Neurol. Disord."},{"issue":"6","key":"10.1016\/j.euroneuro.2018.03.004_bib41","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/hup.2435","article-title":"Human Rho guanine nucleotide exchange factor 11 gene is associated with schizophrenia in a Japanese population","volume":"29","author":"Mizuki","year":"2014","journal-title":"Hum. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2018.03.004_bib42","doi-asserted-by":"crossref","first-page":"E67","DOI":"10.3390\/ijms18010067","article-title":"Human Rho Guanine Nucleotide Exchange Factor 11 (ARHGEF11) regulates dendritic morphogenesis","volume":"18","author":"Mizuki","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.euroneuro.2018.03.004_bib43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejphar.2008.01.019","article-title":"Olanzapine inhibits glycogen synthase kinase-3beta: an investigation by docking simulation and experimental validation","volume":"584","author":"Mohammad","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"9426","key":"10.1016\/j.euroneuro.2018.03.004_bib44","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(04)16458-1","article-title":"Schizophrenia","volume":"363","author":"Mueser","year":"2004","journal-title":"Lancet"},{"issue":"2-3","key":"10.1016\/j.euroneuro.2018.03.004_bib45","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.schres.2004.02.020","article-title":"GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients","volume":"71","author":"Nadri","year":"2004","journal-title":"Schizophr. Res."},{"issue":"29","key":"10.1016\/j.euroneuro.2018.03.004_bib46","doi-asserted-by":"crossref","first-page":"12122","DOI":"10.1523\/JNEUROSCI.0131-13.2013","article-title":"Phosphorylation of threonine-19 of PSD-95 by GSK-3\u03b2 is required for PSD-95 mobilization and long-term depression","volume":"33","author":"Nelson","year":"2013","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.euroneuro.2018.03.004_bib47","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/mp.2014.55","article-title":"Loss of neuronal GSK3\u03b2 reduces dendritic spine stability and attenuates excitatory synaptic transmission via \u03b2-catenin","volume":"20","author":"Ochs","year":"2015","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2018.03.004_bib48","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF02246112","article-title":"Clozapine serum levels and side effects during steady state treatment of schizophrenic patients: a cross-sectional study","volume":"117","author":"Olesen","year":"1995","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.euroneuro.2018.03.004_bib49","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jpsychires.2004.03.008","article-title":"Differential effects of typical and atypical antipsychotics on nerve growth factor and choline acetyltransferase expression in the cortex and nucleus basalis of rats","volume":"38","author":"Parikh","year":"2004","journal-title":"J. Psychiatr. Res."},{"issue":"5","key":"10.1016\/j.euroneuro.2018.03.004_bib50","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.euroneuro.2008.12.012","article-title":"Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SH-SY5Y cells","volume":"19","author":"Park","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2018.03.004_bib51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nn.2741","article-title":"Dendritic spine pathology in neuropsychiatric disorders","volume":"14","author":"Penzes","year":"2011","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.euroneuro.2018.03.004_bib52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0896-6273(01)00193-3","article-title":"The neuronal Rho-GEF Kalirin-7 interacts with PDZ domain-containing proteins and regulates dendritic morphogenesis","volume":"29","author":"Penzes","year":"2001","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.euroneuro.2018.03.004_bib53","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1046\/j.1460-9568.2003.02590.x","article-title":"The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+-induced apoptosis","volume":"17","author":"Qing","year":"2003","journal-title":"Eur. J. Neurosci."},{"issue":"6","key":"10.1016\/j.euroneuro.2018.03.004_bib54","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/00001756-199604260-00024","article-title":"Reduced striatal spine size in schizophrenia: a postmortem ultrastructural study","volume":"7","author":"Roberts","year":"1996","journal-title":"NeuroReport"},{"issue":"3","key":"10.1016\/j.euroneuro.2018.03.004_bib55","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/emm.2007.39","article-title":"Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex","volume":"39","author":"Roh","year":"2007","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.euroneuro.2018.03.004_bib56","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archpsyc.57.4.349","article-title":"Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings","volume":"57","author":"Rosoklija","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5-6","key":"10.1016\/j.euroneuro.2018.03.004_bib57","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.lfs.2008.05.014","article-title":"Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area","volume":"83","author":"Schwieler","year":"2008","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.euroneuro.2018.03.004_bib58","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.euroneuro.2018.03.004_bib59","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.neuron.2011.09.030","article-title":"Common DISC1 polymorphisms disrupt Wnt\/GSK3\u03b2 signaling and brain development","volume":"72","author":"Singh","year":"2011","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.euroneuro.2018.03.004_bib60","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00213-008-1193-9","article-title":"Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response","volume":"200","author":"Souza","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2018.03.004_bib61","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuroscience.2011.09.056","article-title":"The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling","volume":"199","author":"Sutton","year":"2011","journal-title":"Neuroscience"},{"issue":"5649","key":"10.1016\/j.euroneuro.2018.03.004_bib62","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1126\/science.1089681","article-title":"Diverse psychotomimetics act through a common signaling pathway","volume":"302","author":"Svenningsson","year":"2003","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.euroneuro.2018.03.004_bib63","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s12035-013-8414-x","article-title":"GSK-3\u03b2 polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis","volume":"48","author":"Tang","year":"2013","journal-title":"Mol. Neurobiol."},{"issue":"9","key":"10.1016\/j.euroneuro.2018.03.004_bib64","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0006-3223(92)90085-E","article-title":"Drug distribution between blood and brain as a determinant of antipsychotic drug effects","volume":"32","author":"Tsuneizumi","year":"1992","journal-title":"Biol. Psychiatry"},{"issue":"5875","key":"10.1016\/j.euroneuro.2018.03.004_bib65","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1126\/science.1155174","article-title":"Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia","volume":"320","author":"Walsh","year":"2008","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.euroneuro.2018.03.004_bib66","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/070674370705200708","article-title":"Clozapine-induced seizures: recognition and treatment","volume":"52","author":"Wong","year":"2007","journal-title":"Can. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2018.03.004_bib67","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3233\/JAD-130521","article-title":"Lithium attenuates scopolamine-induced memory deficits with inhibition of GSK-3\u03b2 and preservation of postsynaptic components","volume":"37","author":"Wu","year":"2013","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.euroneuro.2018.03.004_bib68","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.neuron.2007.10.005","article-title":"Kalirin-7 controls activity-dependent structural and functional plasticity of dendritic spines","volume":"56","author":"Xie","year":"2007","journal-title":"Neuron"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X18300671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X18300671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:51:16Z","timestamp":1760377876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X18300671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0924977X18300671"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2018.03.004","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of the antipsychotics haloperidol, clozapine, and aripiprazole on the dendritic spine","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2018.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}